| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/22/2009 | US20090022692 Therapeutic agent for heart disease using map kinase tnni3k |
| 01/22/2009 | US20090022669 Compositions for protein delivery via the pulmonary route |
| 01/22/2009 | DE102007032832A1 Fermenting sunchoke, useful e.g. to reduce blood pressure, comprises crushing the sunchoke, mixing mash with microorganisms, providing a cask, pressing mash to juice, filling the juice into a cask, storing, removing and cleaning the juice |
| 01/22/2009 | CA2700477A1 Method for reducing intracranial pressure |
| 01/22/2009 | CA2696833A1 Disease treatment via antimicrobial peptides or their inhibitors |
| 01/22/2009 | CA2695998A1 Novel heterocyclyl compounds |
| 01/22/2009 | CA2693904A1 Heterocyclic compounds useful as mk2 inhibitors |
| 01/22/2009 | CA2692768A1 Compositions for the treatment of metabolic disorders |
| 01/21/2009 | EP2017355A1 Gene associated with arteriosclerotic disease, and use thereof |
| 01/21/2009 | EP2016953A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 01/21/2009 | EP2016951A1 Polypeptides homologous to VEGF and BMP1 |
| 01/21/2009 | EP2016944A2 Angiogenesis inhibitor containing a derivative of rifampicin |
| 01/21/2009 | EP2016942A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 01/21/2009 | EP2016078A2 Pyrrolo- and thiazolo-pyridine compounds as hif modulators |
| 01/21/2009 | EP2016072A1 Factor xa inhibitors |
| 01/21/2009 | EP2015791A1 Formation of therapeutic scar using small particles |
| 01/21/2009 | EP2015754A2 Uses of dpp-iv inhibitors |
| 01/21/2009 | EP2015747A2 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases |
| 01/21/2009 | EP1904477B1 Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 01/21/2009 | EP1562939B1 Carboxamides |
| 01/21/2009 | EP1501791B1 Amino acid analogues |
| 01/21/2009 | EP1499610B1 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 01/21/2009 | EP1487273B1 Compositions and methods for treatment of microbial infections |
| 01/21/2009 | EP1432443B1 Angiotensin peptide-carrier conjugates and uses thereof |
| 01/21/2009 | EP1307588B1 Method for diagnosing or determining a risk for psychosis comprising determining an heterozygous mutation of methylenetetrahydrofolate reductase (MTHFR) |
| 01/21/2009 | EP1286621A4 Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow |
| 01/21/2009 | EP0981352B1 Use of aplidine for the treatment of cardiovascular diseases |
| 01/21/2009 | CN101351462A 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1(VR1) activity |
| 01/21/2009 | CN101348477A Novel pravastatin lactone crystal form |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101347623A Multifunctional nanodevice platform |
| 01/21/2009 | CN101347600A Chinese medicine for treating swelling pain of head |
| 01/21/2009 | CN101347595A Chinese medicine for treating rheumatic heart of children |
| 01/21/2009 | CN101347584A Medicament for treating primary hypertension and preparation method thereof |
| 01/21/2009 | CN101347583A Chinese medicinal composition for treating qi deficiency and phlegm stagnation syndrome type hypertension and preparation technique thereof |
| 01/21/2009 | CN101347560A Medicament for treating gland hyperplasia and angiitis |
| 01/21/2009 | CN101347556A Composition beneficial to cardio-cerebrovascular |
| 01/21/2009 | CN101347538A Medicinal granules for fumigating and washing pudendum |
| 01/21/2009 | CN101347537A Medicinal granules of powder for dispelling toxicity of pudendum and production method |
| 01/21/2009 | CN101347529A Compound dual-purpose natto capsules as medicine or food and preparation thereof |
| 01/21/2009 | CN101347528A Chinese medicinal composition for resisting cardiovascular and cerebrovascular diseases |
| 01/21/2009 | CN101347516A Method for preparing total free anthraquinones extract from rhubarb |
| 01/21/2009 | CN101347503A Salvia root medicinal materials fat soluble component extract and extracting method thereof and method for determining content |
| 01/21/2009 | CN101347498A Fumigating-washing lotion for hemorrhoid |
| 01/21/2009 | CN101347476A Health products capable of reducing blood pressure and preparation thereof |
| 01/21/2009 | CN101347470A Glossy privet fruit total triterpenes extract and total phenols extract as well as preparation method thereof |
| 01/21/2009 | CN101347461A Powder medicinal granules for fumigating-washing hemorrhoid and method of preparing the same |
| 01/21/2009 | CN101347451A Hydrogenous injection having function for treating ischemia-reperfusion injury |
| 01/21/2009 | CN101347441A Applications of anthocyanin and expression of regulation YWHAG gene in preventing and treating atherosclerosis |
| 01/21/2009 | CN101347434A Medicament composition containing renin inhibitor and acidum folicum compound and uses thereof |
| 01/21/2009 | CN101347427A Compound of losartan compound or its medical salt and calcium channel blocker or its medical salt |
| 01/21/2009 | CN101347423A 2-alkoxycarbonyl-3-phenylpropionate derivant-synthesis and uses thereof of novel ACE inhibitor |
| 01/21/2009 | CN101347422A Uses of salvianolic acid A in preventing and/or treating diabetes and complication |
| 01/21/2009 | CN101347408A Kukoline intravenous transfusion preparation |
| 01/21/2009 | CN101347405A Prescription of co-dergocrine mesyiate injection and technique for producing the same |
| 01/21/2009 | CN101347256A Sugar-free corn tassel drink and method for preparing corn tassel drink as well as use |
| 01/21/2009 | CN101347255A Kudzu root drink and preparation method and equipment |
| 01/21/2009 | CN101347235A Cicer arietinum lipid-lowering nourishing powder and method of preparing the same |
| 01/21/2009 | CN101347137A Food prescription for reducing blood pressure and processing technique thereof |
| 01/21/2009 | CN100454021C Method for preparing traditional Chinese medicine for treating circumgyration, and tech. for controlling its quality |
| 01/21/2009 | CN100453549C 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 01/21/2009 | CN100453538C Preparation for chemical composition of Shenmai injection and application in treating cardiovascular and cerebrovascular diseases thereof |
| 01/21/2009 | CN100453530C Compounds and methods for inhibition of expression of VCAM-1 |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/21/2009 | CN100453117C Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker |
| 01/21/2009 | CN100453102C Chinese medicine for treating cardiac and cerebral blood supply insufficiency and its prepn |
| 01/21/2009 | CN100453097C Composite medicine for coronary heart disease and angina pectoris and its preparation |
| 01/21/2009 | CN100453093C Medicine for transient cerebral ischemia attack and its preparation |
| 01/21/2009 | CN100453078C Method for treating primary insomnia |
| 01/21/2009 | CN100453075C Novel association consisting of an anti-atherothrombotic agent and of a platelet antiaggregating agent |
| 01/21/2009 | CN100452990C Extraction method for primary active matter of edible fungi |
| 01/20/2009 | US7479572 Solvent system comprising isopropyl alcohol, water and toluene; recrystallization production of pure, thermodynamically stable form; long lasting bronchodilating effect |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479563 Method of producing polymorphic crystals of donepezil hydrochloride |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479501 Heteroaryl-cyclic acetals |
| 01/20/2009 | US7479491 Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors |
| 01/20/2009 | US7479485 Method of treating arrhythmias |
| 01/20/2009 | CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same |
| 01/20/2009 | CA2465738C Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 01/20/2009 | CA2415438C .alpha. crystalline form of perindopril tert-butylamine salt |
| 01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 01/20/2009 | CA2366268C Pharmaceutical compositions for cns and other disorders |
| 01/20/2009 | CA2365240C Regulation of phospholipase d activity |
| 01/20/2009 | CA2364944C C16 unsaturated fp-selective prostaglandins analogs |
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/20/2009 | CA2325633C Steroidal sapogenins and their derivatives for treating alzheimer's disease |
| 01/20/2009 | CA2312795C The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents |
| 01/20/2009 | CA2289880C A therapeutic agent for intractable vasculitis |
| 01/20/2009 | CA2261040C Pharmaceutical composition comprising combination useful for treatment or prevention of arteriosclerosis or xanthoma |
| 01/15/2009 | WO2009009768A2 METHODS OF INHIBITING THE FORMATION OF AMYLOID-β DIFFUSABLE LIGANDS USING A ACYLHYDRAZIDE COMPOUNDS |
| 01/15/2009 | WO2009009587A2 Apoptosis-modulating protein therapy for proliferative disorders and nanoparticles containing the same |
| 01/15/2009 | WO2009009561A1 Methods and compositions for treating pulmonary hypertension and related diseases and disorders |
| 01/15/2009 | WO2009009173A2 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/15/2009 | WO2009008991A2 Dna-pkcs modulates energy regulation and brain function |
| 01/15/2009 | WO2009008009A1 Novel crystalline form b of carvedilol dihydrogen phosphate |
| 01/15/2009 | WO2009007750A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 01/15/2009 | WO2009007457A2 Compounds and methods for modulating rho gtpases |
| 01/15/2009 | WO2009007348A2 Use of antagonists of g protein coupled receptors (gpcrs) for treating diseases caused by agonistic autoantibodies activated gpcrs |
| 01/15/2009 | WO2009007230A1 Use of nitric oxide releasing compounds in the treatment of chronic pain |